Note 15 - Segments - Operations by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Segment Reporting Information [Line Items]
Revenues	$ 151,669	$ 173,632	$ 458,429	$ 529,504
Cost of revenue	101,776	133,503	316,514	395,653
Gross margin	49,894	40,129	141,915	133,851
Selling, general and administrative	53,804	98,203	172,487	237,191
Research and development	30,078	28,770	91,261	74,789
Amortization of intangible assets	19,531	20,433	58,835	62,290
Other segment items	(101,576)	(121,493)	(101,576)	(121,493)
Segment operating loss	48,056	14,216	(79,092)	(118,926)
Depreciation and amortization	22,739	24,163	69,254	74,137
UNITED STATES
Segment Reporting Information [Line Items]
Revenues	110,923	132,663	342,014	410,422
IRELAND
Segment Reporting Information [Line Items]
Revenues	12,078	11,514	29,299	30,579
CHILE
Segment Reporting Information [Line Items]
Revenues	14,360	16,576	44,895	49,067
SPAIN
Segment Reporting Information [Line Items]
Revenues	6,337	6,297	19,501	17,828
ISRAEL
Segment Reporting Information [Line Items]
Revenues	140	196	351	797
MEXICO
Segment Reporting Information [Line Items]
Revenues	6,737	5,630	19,263	18,621
Other Countries [Member]
Segment Reporting Information [Line Items]
Revenues	1,094	756	3,106	2,190
Service [Member]
Segment Reporting Information [Line Items]
Revenues	95,244	121,271	299,190	377,557
Cost of revenue	80,402	108,847	247,303	325,798
Product [Member]
Segment Reporting Information [Line Items]
Revenues	37,676	39,143	113,261	117,675
Cost of revenue	21,374	24,656	69,211	69,855
Transfer of Intellectual Property and Other [Member]
Segment Reporting Information [Line Items]
Revenues	18,749	13,218	45,978	34,272
Operating Segments [Member] | Pharmaceutical [Member]
Segment Reporting Information [Line Items]
Cost of revenue	21,374	24,657	69,211	69,856
Gross margin	35,052	27,704	90,028	82,091
Selling, general and administrative	13,057	15,161	38,964	44,264
Research and development	29,644	28,244	89,660	73,177
Amortization of intangible assets	16,539	16,495	49,064	49,347
Other segment items	0	0	0	0
Segment operating loss	(24,189)	(32,196)	(87,660)	(84,697)
Depreciation and amortization	18,041	18,043	53,973	53,899
Operating Segments [Member] | Pharmaceutical [Member] | Service [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Operating Segments [Member] | Pharmaceutical [Member] | Product [Member]
Segment Reporting Information [Line Items]
Revenues	37,676	39,143	113,261	117,675
Operating Segments [Member] | Pharmaceutical [Member] | Transfer of Intellectual Property and Other [Member]
Segment Reporting Information [Line Items]
Revenues	18,749	13,218	45,978	34,272
Operating Segments [Member] | Diagnostics [Member]
Segment Reporting Information [Line Items]
Cost of revenue	80,402	108,846	247,303	325,797
Gross margin	14,842	12,425	51,887	51,760
Selling, general and administrative	31,503	70,946	102,828	161,208
Research and development	289	493	1,311	1,545
Amortization of intangible assets	2,992	3,938	9,771	12,943
Other segment items	(101,576)	(121,493)	(101,576)	(121,493)
Segment operating loss	81,634	58,541	39,553	(2,443)
Depreciation and amortization	4,698	6,120	15,281	20,238
Operating Segments [Member] | Diagnostics [Member] | Service [Member]
Segment Reporting Information [Line Items]
Revenues	95,244	121,271	299,190	377,557
Operating Segments [Member] | Diagnostics [Member] | Product [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Operating Segments [Member] | Diagnostics [Member] | Transfer of Intellectual Property and Other [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
Segment Reporting Information [Line Items]
Cost of revenue	0	0	0	0
Gross margin	0	0	0	0
Selling, general and administrative	9,244	12,096	30,695	31,719
Research and development	145	33	290	67
Amortization of intangible assets	0	0	0	0
Other segment items	0	0	0	0
Segment operating loss	(9,389)	(12,129)	(30,985)	(31,786)
Depreciation and amortization	0	0	0	0
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | Service [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | Product [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | Transfer of Intellectual Property and Other [Member]
Segment Reporting Information [Line Items]
Revenues	$ 0	$ 0	$ 0	$ 0